🌍 Introduction
CPZ-413 is a novel entheogenic molecule sourced from an endemic mushroom species — a breakthrough therapeutic experience that opens a new category of medicine entirely its own.
A Novel Entheogenic Molecule
CPZ-413
A breakthrough therapeutic experience
CPZ-413 is a novel entheogenic molecule from an endemic mushroom species — a yuppie speedball of hapeh, mambe, and MDMA woven into one coherent therapeutic arc.
✨ The Experience
Think of it as a yuppie speedball — the grounding clarity of hapeh (tobacco snuff), the focused presence of mambe (buccal coca), and the open-hearted warmth of MDMA — woven into one coherent, ceremonial arc.
🍄 Origin
CPZ-413 is the active molecule of an endemic mushroom species. Its provenance is held in stewardship by indigenous ancestral partners and protected through an exclusive licensing relationship.
🧠 Breakthrough Therapeutic
Unlike serotonergic psychedelics or GABAergic sedatives, CPZ-413 produces a calm body and an active mind — alertness without anxiety, depth without dissociation.
⚡ Cognitive Signature
A characteristic shift toward beta and gamma activity. Improved signal-to-noise of attention, working memory, and emotional processing during the session window.
🫀 Autonomic Signature
Increased vagal tone and heart-rate variability. Relaxation without sedation, presence without overwhelm — the somatic ground for integration.
🌿 Modern Care
CPZ-413 is delivered through MushTryb's TeleHealing protocol: AI-driven intake, licensed practitioner matching, and a guided prep · navigate · integrate arc — from home.
⚠️ Disclaimer
This is an experimental therapeutic medicine. Clinical trials are necessary and ongoing. This document presents emerging, theoretical, and ethnographic perspectives — not medical advice.